Brain Neoplasms
Oncology·MeSH: Brain Neoplasms
Prevalence
3358.2 / 100K
Incidence
1547.2 / 100K/yr
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Temozolomide | BRISTOL MYERS SQUIBB CO (BMY) |
Frequently asked questions
How many drugs are in development for Brain Neoplasms?
BioSniper tracks 1 drug in development for Brain Neoplasms across 1 company.
How many clinical trials target Brain Neoplasms?
There are 5 clinical trials targeting Brain Neoplasms tracked by BioSniper.
What is the prevalence of Brain Neoplasms?
The estimated prevalence of Brain Neoplasms is approximately 3358.2 per 100,000 population.
Deep-dive into Brain Neoplasms
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis